World's Best Scientists 2026 revealed!
Rosette Lidereau

Rosette Lidereau

D-Index & Metrics

Medicine

D-Index
95
Citations
34106
World Ranking
10053
National Ranking
308

Rosette Lidereau publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Rosette Lidereau sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 357 publications — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Rosette Lidereau D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Rosette Lidereau sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 95 D-Index — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Rosette Lidereau is affiliated with the Institute Curie in France. Their research spans several interconnected fields within the biomedical sciences, primarily focusing on biochemistry, genetics, molecular biology, and medicine.

Their work frequently appears in notable publication venues, including:

  • Cells
  • Genome Medicine
  • Human Mutation
  • Cancers
  • Molecular Oncology

The research topics explored by Lidereau cover a range of areas critical to understanding cancer and genetic disorders. These include:

  • Genetics and Neurodevelopmental Disorders
  • Nuclear Receptors and Signaling
  • Cancer Genomics and Diagnostics
  • Cancer Cells and Metastasis
  • BRCA gene mutations in cancer
  • Genomic variations and chromosomal abnormalities
  • CRISPR and Genetic Engineering

Lidereau's scientific contributions also fall within specific subfields such as molecular biology, genetics, oncology, cancer research, and pulmonary and respiratory medicine.

Several frequent collaborators contribute to the breadth and depth of their research efforts. These coauthors include:

  • Keltouma Driouch
  • Ivan Bièche
  • Sandrine M. Caputo
  • François Lallemand
  • Zakia Tariq

Their recent publications demonstrate focus on molecular functions and genetic factors related to cancer development and progression. Selected titles include:

  • Molecular Functions of WWOX Potentially Involved in Cancer Development, 2021, Cells
  • Molecular features of untreated breast cancer and initial metastatic event inform clinical decision-making and predict outcome: long-term results of ESOPE, a single-arm prospective multicenter study, 2021, Genome Medicine
  • Novel germline MET pathogenic variants in French patients with papillary renal cell carcinomas type I, 2021, Human Mutation
  • 5' Region Large Genomic Rearrangements in the BRCA1 Gene in French Families: Identification of a Tandem Triplication and Nine Distinct Deletions with Five Recurrent Breakpoints, 2021, Cancers
  • The high protein expression of FOXO3, but not that of FOXO1, is associated with markers of good prognosis, 2020, Scientific Reports

Best Publications

  • Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.

    Lionel Apetoh;François Ghiringhelli;Antoine Tesniere;Antoine Tesniere;Antoine Tesniere;Michel Obeid;Michel Obeid;Michel Obeid

  • Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors

    François Ghiringhelli;Lionel Apetoh;Antoine Tesniere;Antoine Tesniere;Antoine Tesniere;Laetitia Aymeric;Laetitia Aymeric;Laetitia Aymeric

  • Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer

    Marc Buyse;Sherene Loi;Laura van't Veer;Giuseppe Viale

  • Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series,

    Christine Desmedt;Fanny Piette;Sherene Loi;Yixin Wang

  • The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy.

    Lionel Apetoh;François Ghiringhelli;Antoine Tesniere;Antoine Tesniere;Antoine Tesniere;Alfredo Criollo;Alfredo Criollo;Alfredo Criollo

  • The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.

    Magali Olivier;Anita Langerød;Patrizia Carrieri;Jonas Bergh

  • A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma

    Corine Bertolotto;Fabienne Lesueur;Sandy Giuliano;Thomas Strub

  • Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas.

    Chantal Escot;Charles Theillet;Rosette Lidereau;Frederique Spyratos

  • Predisposing Gene for Early-Onset Prostate Cancer, Localized on Chromosome 1q42.2-43

    Philippe Berthon;Antoine Valeri;Annick Cohen-Akenine;Eric Drelon

  • Expression Analysis of DNA Methyltransferases 1, 3A, and 3B in Sporadic Breast Carcinomas

    Igor Girault;Sengül Tozlu;Rosette Lidereau;Ivan Bièche

  • Reduction to homozygosity of genes on chromosome 11 in human breast neoplasia

    Iqbal Unnisa Ali;Rosette Lidereau;Charles Theillet;Robert Callahan

  • Genetic alterations in breast cancer.

    Ivan Bièche;Rosette Lidereau

  • Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays.

    Alain Latil;Ivan Bièche;Dominique Vidaud;Rosette Lidereau

  • Down-regulation of BRCA1 Expression by miR-146a and miR-146b-5p in Triple Negative Sporadic Breast Cancers

    Amandine I Garcia;Monique Buisson;Pascale Bertrand;Ruth Rimokh

  • A refined molecular taxonomy of breast cancer

    M Guedj;L Marisa;A de Reynies;B Orsetti

  • Molecular profiling of inflammatory breast cancer: identification of a poor-prognosis gene expression signature.

    Ivan Bièche;Florence Lerebours;Sengül Tozlu;Marc Espie

  • Real-Time Reverse Transcription-PCR Assay for Future Management of ERBB2-based Clinical Applications

    Ivan Bièche;Peter Onody;Ingrid Laurendeau;Martine Olivi

  • Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay

    Ivan Bièche;Ingrid Laurendeau;Sengül Tozlu;Martine Olivi

  • Loss of a c-H-ras-1 allele and aggressive human primary breast carcinomas.

    Charles Theillet;Rosette Lidereau;Chantal Escot;Paula Hutzell

  • Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach

    S Tozlu;I Girault;S Vacher;J Vendrell

Frequent Co-Authors

Ivan Bièche
Ivan Bièche Institute Curie
Robert Callahan
Robert Callahan National Institutes of Health
Olivier Cussenot
Olivier Cussenot Université Paris Cité
Charles Theillet
Charles Theillet University of Montpellier
Giorgio R. Merlo
Giorgio R. Merlo University of Turin
Michel Vidaud
Michel Vidaud Université Paris Cité
Yves-Jean Bignon
Yves-Jean Bignon Centre Jean Perrin
Thierry Frebourg
Thierry Frebourg Grenoble Alpes University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a medical career in the USA, numerous online degrees offer alternative or complementary paths in healthcare. Many learners explore healthcare administration programs to build foundational knowledge in healthcare leadership, policy, and facility management—vital skills for those interested in running hospitals or clinics.

Nursing remains a popular route, especially for registered nurses seeking to advance. RN to FNP bridge programs help working nurses transition into family nurse practitioner roles, expanding their clinical scope and job opportunities.

For those drawn to preventive care and lifestyle medicine, an online nutritionist degree teaches the science of diet and wellness, preparing graduates for rewarding positions in patient counseling or public health.

Aspiring healthcare executives can also consider accredited MHA programs, which deliver advanced management and leadership training necessary for high-level healthcare administration roles.

These flexible online pathways can boost your expertise and expand your career options in the dynamic field of medicine and healthcare.

Best Scientists Citing Rosette Lidereau

Trending Scientists

Recently Published Articles